10% Owner Opaleye Management Adds $1.57M to Alpha Cognition Stake, Total Holdings Near 3M Shares

summarizeSummary

10% owner Opaleye Management purchased $1.57 million of Alpha Cognition stock, adding to a $1 million buy in June. The continued accumulation by a large institutional holder suggests confidence in the company's outlook.

check_boxKey Events · Ownership and Investor Activity · ACOG

• 10% Owner Buys $1.57M More Stock

  Opaleye Management acquired 200,086 shares at $7.80–$7.83, totaling $1,565,499, increasing its stake to 2,995,193 shares.

• Follows $1M Purchase in June

  This is the second large open-market purchase by Opaleye in a month, following a nearly $1 million buy reported on June 29, 2026.

• Institutional Conviction Signal

  The back-to-back purchases by a 10% owner suggest strong belief in Alpha Cognition's value, especially after positive BEACON study results for Zunveyl in Alzheimer's disease.

• Financial Context: Cash Burn and Control Weakness

  The buying comes despite Alpha Cognition's Q1 2026 report of increased net loss, higher cash burn, and a material weakness in internal controls.

auto_awesomeAnalysis · ACOG · Life Sciences

Opaleye Management, a 10% owner, bought another $1.57 million of Alpha Cognition stock at $7.80–$7.83, just weeks after a $1 million purchase in late June. The back-to-back buying by a large institutional holder signals conviction in the company's prospects, particularly following positive Alzheimer's drug data in June. However, as a financial investor rather than a company insider, the signal is somewhat tempered — this is portfolio management, not operational insight. Still, the accumulation to nearly 3 million shares is a notable vote of confidence amid the company's cash burn and internal control weaknesses.